164 related articles for article (PubMed ID: 23093276)
1. Human epididymis protein 4 (HE4) in benign and malignant diseases.
Hertlein L; Stieber P; Kirschenhofer A; Krocker K; Nagel D; Lenhard M; Burges A
Clin Chem Lab Med; 2012 Dec; 50(12):2181-8. PubMed ID: 23093276
[TBL] [Abstract][Full Text] [Related]
2. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
Lenhard M; Stieber P; Hertlein L; Kirschenhofer A; Fürst S; Mayr D; Nagel D; Hofmann K; Krocker K; Burges A
Clin Chem Lab Med; 2011 Sep; 49(12):2081-8. PubMed ID: 21923475
[TBL] [Abstract][Full Text] [Related]
4. Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer.
Nagy B; Bhattoa HP; Steiber Z; Csobán M; Szilasi M; Méhes G; Müller M; Lázár J; Kappelmayer J; Antal-Szalmás P
Clin Chem Lab Med; 2014 Nov; 52(11):1639-48. PubMed ID: 24829194
[TBL] [Abstract][Full Text] [Related]
5. Human Epididymis Protein 4 (HE4) Reference Limits in Polish Population of Healthy Women, Pregnant Women, and Women with Benign Ovarian Tumors.
Gasiorowska E; Kluz T; Lipski D; Warchoł W; Tykarski A; Nowak-Markwitz E
Dis Markers; 2019; 2019():3890906. PubMed ID: 31583027
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis.
Wu L; Dai ZY; Qian YH; Shi Y; Liu FJ; Yang C
Int J Gynecol Cancer; 2012 Sep; 22(7):1106-12. PubMed ID: 22854652
[TBL] [Abstract][Full Text] [Related]
8. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.
Escudero JM; Auge JM; Filella X; Torne A; Pahisa J; Molina R
Clin Chem; 2011 Nov; 57(11):1534-44. PubMed ID: 21933899
[TBL] [Abstract][Full Text] [Related]
9. HE4 and ROMA index in Czech postmenopausal women.
Novotny Z; Presl J; Kucera R; Topolcan O; Vrzalova J; Fuchsova R; Betincova L; Rokyta Z
Anticancer Res; 2012 Sep; 32(9):4137-40. PubMed ID: 22993374
[TBL] [Abstract][Full Text] [Related]
10. Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125.
Li PL; Zhang X; Li TF; Wang LL; Du LT; Yang YM; Li J; Wang HY; Zhang Y; Wang CX
Clin Chim Acta; 2015 Jan; 439():148-53. PubMed ID: 25445414
[TBL] [Abstract][Full Text] [Related]
11. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
[TBL] [Abstract][Full Text] [Related]
12. Serum human epididymis protein 4 (HE4) may be a better tumor marker in early lung cancer.
Zeng Q; Liu M; Zhou N; Liu L; Song X
Clin Chim Acta; 2016 Apr; 455():102-6. PubMed ID: 26851650
[TBL] [Abstract][Full Text] [Related]
13. Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis.
Lin J; Qin J; Sangvatanakul V
Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):81-5. PubMed ID: 23228410
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of HE4 for ovarian cancer: a meta-analysis.
Yu S; Yang HJ; Xie SQ; Bao YX
Clin Chem Lab Med; 2012 Feb; 50(8):1439-46. PubMed ID: 22868811
[TBL] [Abstract][Full Text] [Related]
15. Increased human epididymis protein 4 in benign gynecological diseases complicated with chronic renal insufficiency patients.
Lv YW; Yang L; Zhang M; Jiang LH; Niu JH; Hou J; Cui XH
Genet Mol Res; 2015 Mar; 14(1):2156-61. PubMed ID: 25867363
[TBL] [Abstract][Full Text] [Related]
16. Urinary concentrations of human epidydimis secretory protein 4 (He4) in the diagnosis of ovarian cancer: a case--control study.
Macuks R; Baidekalna I; Donina S
Asian Pac J Cancer Prev; 2012; 13(9):4695-8. PubMed ID: 23167404
[TBL] [Abstract][Full Text] [Related]
17. Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China.
Li L; Wan J; Cai G; Yuan L; Liang J; Song J; Wang F; Liu M
Clin Chim Acta; 2016 Aug; 459():170-176. PubMed ID: 27302312
[TBL] [Abstract][Full Text] [Related]
18. Serum Human Epididymis Protein-4 (HE4) - A novel Approach to Differentiate Malignant Frombenign Breast Tumors.
Sai Baba KSS; Rehman MA; Pradeep Kumar J; Fatima M; Raju GSN; Uppin SG; Mohammed N
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2509-2507. PubMed ID: 34452565
[TBL] [Abstract][Full Text] [Related]
19. Human epididymis protein 4 reference intervals in a multiethnic asian women population.
Mokhtar N; Thevarajah M; Ma N; M I
Asian Pac J Cancer Prev; 2012; 13(12):6391-5. PubMed ID: 23464464
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
Azzam AZ; Hashad DI; Kamel NA
Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]